346 related articles for article (PubMed ID: 17037948)
1. Polycystic ovary syndrome in adolescents: current and future treatment options.
Mastorakos G; Lambrinoudaki I; Creatsas G
Paediatr Drugs; 2006; 8(5):311-8. PubMed ID: 17037948
[TBL] [Abstract][Full Text] [Related]
2. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
[TBL] [Abstract][Full Text] [Related]
3. Adolescence and polycystic ovary syndrome: current concepts on diagnosis and treatment.
Spritzer PM; Motta AB
Int J Clin Pract; 2015 Nov; 69(11):1236-46. PubMed ID: 26289303
[TBL] [Abstract][Full Text] [Related]
4. Polycystic ovary syndrome (PCOS) and the accompanying disorders of glucose homeostasis among girls at the time of puberty.
Otto-Buczkowska E; Grzyb K; Jainta N
Pediatr Endocrinol Diabetes Metab; 2018; 24(1):40-44. PubMed ID: 30083660
[TBL] [Abstract][Full Text] [Related]
5. [Metformin, an efficacious drug in the treatment of polycystic ovary syndrome].
Hahn S; Quadbeck B; Elsenbruch S; Gärtner R; Finke R; Mann K; Janssen OE
Dtsch Med Wochenschr; 2004 May; 129(19):1059-64. PubMed ID: 15136950
[TBL] [Abstract][Full Text] [Related]
6. Insulin sensitizers in adolescents with polycystic ovary syndrome.
LE TN; Wickham EP; Nestler JE
Minerva Pediatr; 2017 Oct; 69(5):434-443. PubMed ID: 28497664
[TBL] [Abstract][Full Text] [Related]
7. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.
Kazerooni T; Dehghan-Kooshkghazi M
Gynecol Endocrinol; 2003 Feb; 17(1):51-6. PubMed ID: 12724019
[TBL] [Abstract][Full Text] [Related]
8. Endocrine and metabolic characteristics in polycystic ovary syndrome.
Glintborg D
Dan Med J; 2016 Apr; 63(4):. PubMed ID: 27034186
[TBL] [Abstract][Full Text] [Related]
9. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and Management of Polycystic Ovary Syndrome in Adolescent Girls.
Lanzo E; Monge M; Trent M
Pediatr Ann; 2015 Sep; 44(9):e223-30. PubMed ID: 26431241
[TBL] [Abstract][Full Text] [Related]
11. Insulin resistance, polycystic ovary syndrome and metformin.
Pugeat M; Ducluzeau PH
Drugs; 1999; 58 Suppl 1():41-6; discussion 75-82. PubMed ID: 10576524
[TBL] [Abstract][Full Text] [Related]
12. Treatment options of polycystic ovary syndrome in adolescence.
Zapanti E; Kiapekou E; Loutradis D
Pediatr Endocrinol Rev; 2006 Jan; 3 Suppl 1():208-13. PubMed ID: 16641862
[TBL] [Abstract][Full Text] [Related]
13. Sensitization to insulin in adolescent girls to normalize hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism after precocious pubarche.
Ibáñez L; Valls C; Potau N; Marcos MV; de Zegher F
J Clin Endocrinol Metab; 2000 Oct; 85(10):3526-30. PubMed ID: 11061495
[TBL] [Abstract][Full Text] [Related]
14. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.
Diamanti-Kandarakis E; Kouli CR; Bergiele AT; Filandra FA; Tsianateli TC; Spina GG; Zapanti ED; Bartzis MI
J Clin Endocrinol Metab; 1999 Nov; 84(11):4006-11. PubMed ID: 10566641
[TBL] [Abstract][Full Text] [Related]
15. Polycystic ovary syndrome in adolescence.
Driscoll DA
Ann N Y Acad Sci; 2003 Nov; 997():49-55. PubMed ID: 14644809
[TBL] [Abstract][Full Text] [Related]
16. Polycystic ovary syndrome in adolescence--a therapeutic conundrum.
Homburg R; Lambalk CB
Hum Reprod; 2004 May; 19(5):1039-42. PubMed ID: 15016769
[TBL] [Abstract][Full Text] [Related]
17. Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity.
Ibáñez L; de Zegher F
J Clin Endocrinol Metab; 2004 Apr; 89(4):1592-7. PubMed ID: 15070917
[TBL] [Abstract][Full Text] [Related]
18. Effects of the insulin sensitizer pioglitazone on menstrual irregularity, insulin resistance and hyperandrogenism in young women with polycystic ovary syndrome.
Stabile G; Borrielli I; Artenisio AC; Bruno LM; Benvenga S; Giunta L; La Marca A; Volpe A; Pizzo A
J Pediatr Adolesc Gynecol; 2014 Jun; 27(3):177-82. PubMed ID: 24814528
[TBL] [Abstract][Full Text] [Related]
19. Polycystic ovary syndrome in adolescents.
Kent SC; Legro RS
Adolesc Med; 2002 Feb; 13(1):73-88, vi. PubMed ID: 11841956
[TBL] [Abstract][Full Text] [Related]
20. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
